Bionano Genomics, Inc. (BNGO) NASDAQ
1.26
+0.00999994(+0.80%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.26
+0.00999994(+0.80%)
Currency In USD
| Previous Close | 1.25 |
| Open | 1.24 |
| Day High | 1.27 |
| Day Low | 1.23 |
| 52-Week High | 5.5 |
| 52-Week Low | 1.06 |
| Volume | 148,683 |
| Average Volume | 306,085 |
| Market Cap | 4.14M |
| PE | -0.28 |
| EPS | -4.46 |
| Moving Average 50 Days | 1.22 |
| Moving Average 200 Days | 1.72 |
| Change | 0.01 |
Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026
GlobeNewswire Inc.
Mar 09, 2026 8:05 PM GMT
SAN DIEGO, March 09, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Monday, March 23, 2026, at 4:30 p.m. Eastern Time to report financial results for the fourth
Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale
GlobeNewswire Inc.
Feb 27, 2026 1:00 PM GMT
SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from the fourth and final day of Symposium 2026. Day 4 featured updates from some of the most advanced and high-volume cytogenetics and mo
10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders
GlobeNewswire Inc.
Feb 26, 2026 1:00 PM GMT
SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how thes